STOCK TITAN
  1. Home
  2. Sec-filings
  3. COCO
  4. [Form 4] Vita Coco Company, Inc. Insider Trading Activity

Vita Coco (COCO) COO sells 20,000 and 2,334 shares via 10b5-1

Vita Coco (COCO) reported insider activity by Chief Operating Officer Jonathan Burth.

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco (COCO) reported insider activity by Chief Operating Officer Jonathan Burth. On 10/29/2025, he exercised stock options at $10.178 per share for 2,334 and 20,000 shares (code M), then sold the same amounts (code S) at weighted average prices of $47.948 and $45.711, respectively, pursuant to a Rule 10b5-1 trading plan.

Following these transactions, Burth directly beneficially owned 76,127 shares of common stock. The filing also lists multiple outstanding non-qualified stock options with stated exercise prices and expirations, including grants expiring between 2029 and 2035, with various vesting schedules as disclosed.

Positive

  • None.

Negative

  • None.
Insider Burth Jonathan
Role Chief Operating Officer
Sold 22,334 shs ($1.03M)
Approx. gross sale proceeds $1.03M
Approx. exercise cost $227K
Approx. pre-tax spread $799K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 20,000 $0.00 $0.00
Exercise Non-Qualified Stock Option (right to buy) 2,334 $0.00 $0.00
Exercise Common Stock 2,334 $10.178 $24K
Sale Common Stock 2,334 $47.948 $112K
Exercise Common Stock 20,000 $10.178 $204K
Sale Common Stock 20,000 $45.711 $914K
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 400,758 contracts for 171,317 underlying shares (Direct); Common Stock — 76,127 shares (Direct)
Footnotes (10)
  1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $46.38, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4. The stock option is fully vested and currently exercisable.
  5. F5. The stock option is fully vested and currently exercisable.
  6. F6. The stock option vests in four equal annual installments beginning on November 27, 2022.
  7. F7. The stock option vests in three equal annual installments beginning on August 15, 2025.
  8. F8. The stock option vests in four equal annual installments beginning on March 10, 2024.
  9. F9. The stock option vests in four equal annual installments beginning on March 4, 2025.
  10. F10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did COCO's COO report?
On 10/29/2025, the COO exercised options at $10.178 for 2,334 and 20,000 shares, then sold the same amounts at weighted averages of $47.948 and $45.711 under a Rule 10b5-1 plan.

How many COCO shares did the COO hold after the transactions?
He directly beneficially owned 76,127 shares following the reported transactions.

Were the COCO share sales under a 10b5-1 plan?
Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan.

What prices were the COCO shares sold at?
Weighted averages of $47.948 (range $47.71–$48.00) for 2,334 shares and $45.711 (range $45.00–$46.38) for 20,000 shares.

What options did the COCO COO exercise?
Non-qualified stock options with a $10.178 exercise price covering 2,334 and 20,000 shares; noted as fully vested and currently exercisable.

Does the filing list other outstanding COCO options?
Yes. It lists several non-qualified stock options with expirations from 2029 to 2035 and vesting schedules as disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burth Jonathan
(Last) (First) (Middle)
111 5TH AVENUE
2ND FLOOR
(Street)
NEW YORK NY 10003
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/29/2025 M 2,334 A $10.178 78,461 D
Common Stock 10/29/2025 S(1) 2,334 D $47.948(2) 76,127 D
Common Stock 10/29/2025 M 20,000 A $10.178 96,127 D
Common Stock 10/29/2025 S(1) 20,000 D $45.711(3) 76,127 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 10/29/2025 M 20,000 (4) 12/16/2029 Common Stock 20,000 $0.0 8,825 D
Non-Qualified Stock Option (right to buy) $10.178 10/29/2025 M 2,334 (4) 02/10/2030 Common Stock 2,334 $0.0 220,616 D
Non-Qualified Stock Option (right to buy) $10.178 (5) 01/11/2031 Common Stock 34,125 34,125 D
Non-Qualified Stock Option (right to buy) $15 (6) 10/21/2031 Common Stock 58,043 58,043 D
Non-Qualified Stock Option (right to buy) $15.36 (7) 08/15/2032 Common Stock 42,980 42,980 D
Non-Qualified Stock Option (right to buy) $16.91 (8) 03/10/2033 Common Stock 14,205 14,205 D
Non-Qualified Stock Option (right to buy) $26.18 (9) 03/04/2034 Common Stock 8,746 8,746 D
Non-Qualified Stock Option (right to buy) $33.36 (10) 03/04/2035 Common Stock 13,218 13,218 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $46.38, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. The stock option is fully vested and currently exercisable.
5. The stock option is fully vested and currently exercisable.
6. The stock option vests in four equal annual installments beginning on November 27, 2022.
7. The stock option vests in three equal annual installments beginning on August 15, 2025.
8. The stock option vests in four equal annual installments beginning on March 10, 2024.
9. The stock option vests in four equal annual installments beginning on March 4, 2025.
10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
By: Alison Klein, Attorney-in-Fact For: Jonathan Burth 10/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on COCO

Trending in the feed

Open the live feed